Abstract
Several major advances in the field of neonatal cardiac surgery have improved the outcome of these severely ill patients. Among the preoperative advances are improvement in the management of patients with single ventricle equivalents, prenatal diagnosis, and interventional procedures. Intraoperative advances include better understanding of the inflammatory process caused by cardiopulmonary bypass and ways to manage it, newer techniques for treating hypoplastic left heart syndrome and aortic valve disease, and primary repair of complex lesions. Postoperative refinements in managing pulmonary hypertension, low cardiac output state, and ventricular assist devices have decreased surgical mortality and morbidity. Although his primary interest has been adult cardiac surgery, Dr. Geha has contributed directly and indirectly to these advances.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bull C (1999) Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Pediatric Cardiac Association. Lancet 354(9186):1231–1247
Rodrigez JG, Holmes R, Martin R, et al. (1998) Prognosis following prenatal diagnosis of heart malformations. Early Hum Dev 52:13–20
Day RS, Tani LY, Minich LL, et al. (1995) Congenital heart disease with ductal-dependent systemic perfusion:doppler ultrasonography flow velocities are altered by changes in the fraction of inspired oxygen. J Heart Lung Transplant 14:718–725
Kronon MT, Allen BS, Halldorsson A, et al. (1999) L-arginine, prostaglandin, and white cell filtration equally improve myocardial protection in stressed neonatal hearts. J Thorac Cardiovasc Surg 188:665–673
Kennen HT, Thiagarajan R, Stephens KE, et al. (2000) Pulmonary function after modified venovenous ultrafiltration in infants:a prospective randomized trial. J Thorac Cardiovasc Surg 119:501–505; discussion 506–507
Sakurai H, Maeda M, Sai N, et al. (1999) Extended use of hemofiltration and high perfusion flow rate in cardiopulmonary bypass improves perioperative fluid balance in neonates and infants. Ann Thorac Surg 5:94–100
Bronicki RA, Backer CL, Baden HP, et al. (2000) Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 69:1490–1495
D’Erico CC, Munro HM, Bove EL (1999) Pro: the routine use of aprotinin during pediatric cardiac surgery is a benefit. J Cardiothorac Vasc Anesth 13:782–784
Wippermann CF, Schmid FX, Eberle B, et al. (1999) Reduced inotropic support after aprotinin therapy during pediatric cardiac operations. Ann Thorac Surg 67:173–176
Borwoski A, Raji MR, Eichstaedt HC, et al. (1998) Myocardial protection by pressure and volume-controlled continuous hypothermic coronary perfusion in combination with esmolol and nitroglycerine for correction of congenital heart defects in pediatric risk patients. Eur J Cardiothorac Surg 14:243–249
Del Nido PJ (1997) Myocardial protection for neonates and infants. Ann Thorac Surg 67:878–879
Bellinger DC, Wypij D, DuPlessis AJ, et al. (2001) Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg 121:374–383
Kirkahm FJ (1998) Recognition and prevention of neurological complications in pediatric cardiac surgery. Pediatr Cardiol 19:331–345
Skaryak LA, Lodge AJ, Kirshbom PM, et al. (1996) Low-flow cardiopulmonary bypass produces greater pulmonary dysfunction than circulatory arrest. Ann Thorac Surg 62:284–288
Beghetti M, Morris K, Cox P, et al. (1999) Inhaled nitric oxide differentiates pulmonary vasospasm from vascular obstruction after surgery for congenital heart disease. Intensive Care Med 25:1126–1130
Miller OI, Tang SF, Keech A, et al. (2000) Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomized double-blind study. Lancet 346(9240):1464–1469
Finer NN, Barrinton KJ (2000) Nitric oxide therapy for the newborn infant. Semin Perinatol 24:59–65
Skimming JW (1998) Nitric oxide inhalation therapy for newborn infants. Curr Probl Pediatr 28:253–264
Jaillard S, Pierrat V, Truffert P, et al. (2000) Two years follow-up of newborn infants after extracorporeal membrane oxygenation (ECMO). Eur J Cardiothorac Surg 18:328–333
Rais-Bahrami K, Short BL (2000) The current status of neonatal extracorporeal membrane oxygenation. Semin Perinatol 24:406–417
Khan A, Gazzaniga AB (1996) Treatment of low cardiac output syndrome in paediatric patients with cardiac failure. Cardiovasc Surg 83 Suppl 2(1–4):91–100
Daebritz SH, Nollert GD, Zurakowski D, et al. (2000) Results of Norwood Stage 1 operation: comparison of hypoplastic left heart syndrome with other malformations. J Thorac Cardiovasc Surg 119:358–367
Hraska V, Nosal M, Sykora P, et al. (2000) Results of modified Norwood’s operation for hypoplastic left heart syndrome. Eur J Cardiothorac Surg 18:214–219
Tweddell JS, Hoffman GM, Fedderly RT, et al. (2000) Patients at risk for low systemic oxygen delivery after the Norwood procedure. Ann Thorac Surg 69:1893–1899
Marino BS, Wernovsky G, Rychik J, et al. (1999) Early results of the Ross procedure in simple and complex left heart disease. Circulation 100(19 Suppl III):62–66
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
el-Zein, C., Ilbawi, M.N. Recent Advances in Neonatal Cardiac Surgery. World J Surg 32, 340–345 (2008). https://doi.org/10.1007/s00268-007-9418-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-007-9418-3